C29 inhibited the ERK/MAP Kinase and PI3K/AKT signaling pathways, two major pathways involved in cell proliferation, of naive and resistant RCC and HNSCC cells (Figure 5A-B). Here, AKT1 is linked to head and neck squamous cell carcinoma.